Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
206.60    4.00 (1.97%)
Bid:
201.60
Ask:
204.20
Spread: 2.60 (1.29%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

14 Jul 2025 07:00

RNS Number : 8120Q
Ashmore Group PLC
14 July 2025
 

Ashmore Group plc14 July 2025

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2025.

Assets under management

Theme

Actual31 March 2025

(US$ billion)

Estimated30 June 2025

(US$ billion)

Movement(%)

- External debt

7.2

7.4

+3%

- Local currency

14.0

14.2

+1%

- Corporate debt

4.9

5.2

+6%

- Blended debt

11.7

11.7

-

Fixed income

37.8

38.5

+2%

Equities

6.8

7.5

+10%

Alternatives

1.6

1.6

-

Total

46.2

47.6

+3%

 

Assets under management increased by US$1.4 billion over the period, comprising positive investment performance of US$2.2 billion and net outflows of US$0.8 billion.

Net flows improved from the prior quarter with significantly lower redemptions, against a backdrop of continuing trade tensions and geopolitical uncertainty. Subscription levels were consistent and investors' risk appetite generally remains subdued given macro events. New equity mandates were funded in the period, an impact debt strategy was launched and Ashmore opened a new office in Qatar. Overall, net flows were positive in equities, flat in external debt and alternatives, and there were net outflows in the blended debt, local currency and corporate debt themes.

Emerging markets indices delivered positive returns of between +2% and +12% over the three months, outperforming many developed markets and reflecting robust underlying fundamentals together with the impact of US dollar weakness that underpinned higher returns particularly in local currency and equities. Ashmore continues to deliver outperformance for clients across a broad range of strategies and the proportion of Group AuM outperforming benchmarks over one, three and five years has improved since the start of the calendar year.

 

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Emerging markets continue to outperform developed world equity and bond markets, in part due to the ongoing weakness in the US dollar. Consequently, investors are beginning to rebalance portfolios away from heavily overweight US positions towards more attractively valued asset classes, including those in EM. While recent EM mutual fund inflows have been concentrated in exchange traded funds, previously this has been a precursor to broader institutional behaviour.

"Ashmore's diversified product range and delivery of investment outperformance for clients means it is well-positioned to participate in the reallocation opportunity, as investors move back up to target weights and then address the structural underweights compared with EM's representation in global indices."

 

 

Notes

Local currency AuM includes US$7.9 billion of AuM managed in overlay/liquidity strategies (31 March 2025: US$7.9 billion).

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.3704 at 30 June 2025 (30 June 2024: 1.2641). For the translation of US dollar management fees, the average GBP:USD exchange rate for the financial year was 1.2970 (FY2024: 1.2609).

Ashmore will announce its results in respect of the year ending 30 June 2025 on 5 September 2025.

 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278 ir@ashmoregroup.com

Cardew GroupTom Allison +44 (0)7789 998020Will Baldwin-Charles +44 (0)7834 524833 ashmore@cardewgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRDTILLIE
Date   Source Headline
19th Aug 20242:55 pmRNSHolding(s) in Company
12th Jul 20247:00 amRNSTrading statement
31st May 20244:17 pmRNSHolding(s) in Company
31st May 20243:15 pmRNSDirector/PDMR Shareholding
1st May 20243:01 pmRNSDirectorate Change
1st May 202411:11 amRNSDirector/PDMR Shareholding
18th Apr 20241:11 pmRNSDirectorate Change
15th Apr 20247:00 amRNSTrading Statement
18th Mar 20243:30 pmRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNSTrading Statement
21st Dec 20239:30 amRNSHolding(s) in Company
11th Dec 202311:21 amRNSDirector/PDMR Shareholding
18th Oct 20232:13 pmRNSResult of AGM
13th Oct 20237:00 amRNSTrading Statement
19th Sep 202311:00 amRNSDirector/PDMR Shareholding
19th Sep 202310:08 amRNSHolding(s) in Company
15th Sep 20235:06 pmRNSHolding(s) in Company
14th Sep 20232:56 pmRNSNotice of AGM
14th Sep 202310:29 amRNSDirector/PDMR Shareholding
6th Sep 20237:00 amRNSFinal Results
14th Jul 20231:51 pmRNSHolding(s) in Company
14th Jul 20237:00 amRNSTrading Statement
11th Jul 20232:10 pmRNSHolding(s) in Company
10th Jul 20232:48 pmRNSHolding(s) in Company
30th Jun 20235:11 pmRNSHolding(s) in Company
29th Jun 20239:09 amRNSHolding(s) in Company
14th Jun 20239:23 amRNSHolding(s) in Company
19th May 20238:35 amRNSDirector Declaration
21st Apr 20237:00 amRNSDirectorate Change
17th Apr 20237:00 amRNSTrading Statement
14th Apr 20239:30 amRNSAGM Statement
31st Mar 20232:33 pmRNSDirector/PDMR Shareholding
17th Mar 202310:21 amRNSDirector/PDMR Shareholding
13th Mar 202310:23 amRNSAudit tender process
8th Mar 20239:48 amRNSHolding(s) in Company
27th Feb 20239:41 amRNSHolding(s) in Company
16th Feb 20234:53 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:02 pmRNSHolding(s) in Company
25th Jan 20233:25 pmRNSHolding(s) in Company
24th Jan 20236:12 pmRNSHolding(s) in Company
23rd Jan 20239:01 amRNSHolding(s) in Company
19th Jan 20234:55 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Statement
12th Jan 20233:26 pmRNSHolding(s) in Company
11th Jan 20234:27 pmRNSHolding(s) in Company
9th Jan 20233:13 pmRNSHolding(s) in Company
5th Jan 20235:14 pmRNSHolding(s) in Company
16th Dec 20223:52 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.